Fig. 3.
Fig. 3. (A) RNase protection assay of reticulocyte RNA, using the β654 riboprobe. Protected fragments of normal and aberrant transcripts are 129 bp and 189 bp, respectively. The lanes are represented by M: Marker (pBR322 DNA-Msp I); 1: Proband LI-1; 2: Proband LII-3; lanes 3 to 8 are the asymptomatic heterozygotes; N: normal; 9: CII-1 (β IVS 2-654 homozygote) and 10: AH (β IVS 2-654/(Aγδβ)0 thalassemia). (B) RNase protection assay of RNA extracted from erythroblasts, cultured from CD34+ peripheral progenitors, using the β654 probe. Protected fragments of the normal (βN) and aberrantly spliced (β654) transcripts, at 129 and 189 bp, are indicated. The lanes are represented by M, pBR322 DNA-Msp I; 1, RH (5 μg RNA); 2, RH (1 μg RNA); 3, normal control.

(A) RNase protection assay of reticulocyte RNA, using the β654 riboprobe. Protected fragments of normal and aberrant transcripts are 129 bp and 189 bp, respectively. The lanes are represented by M: Marker (pBR322 DNA-Msp I); 1: Proband LI-1; 2: Proband LII-3; lanes 3 to 8 are the asymptomatic heterozygotes; N: normal; 9: CII-1 (β IVS 2-654 homozygote) and 10: AH (β IVS 2-654/(Aγδβ)0 thalassemia). (B) RNase protection assay of RNA extracted from erythroblasts, cultured from CD34+ peripheral progenitors, using the β654 probe. Protected fragments of the normal (βN) and aberrantly spliced (β654) transcripts, at 129 and 189 bp, are indicated. The lanes are represented by M, pBR322 DNA-Msp I; 1, RH (5 μg RNA); 2, RH (1 μg RNA); 3, normal control.

Close Modal

or Create an Account

Close Modal
Close Modal